IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels
Interleukin (IL)-17A has a direct contribution in early induction and late chronic stages of various inflammatory diseases. In vitro and in vivo experiments have first characterized its local effects on different cell types and then its systemic effects. For instance, IL-17 axis is now identified as...
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
Frontiers Media S.A.
2019-01-01
|
| Ráidu: | Frontiers in Medicine |
| Fáttát: | |
| Liŋkkat: | https://www.frontiersin.org/article/10.3389/fmed.2018.00364/full |